Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00316602
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2006-04-20
Brief Title:
A Phase II Study on Immunogenicity and Safety of MVA-BN IMVAMUNE Smallpox Vaccine in Subjects With Atopic Dermatitis
Sponsor:
Bavarian Nordic
Organization:
Bavarian Nordic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-20
First Submit QC Date:
April 20 2006
Study First Post Date:
2006-04-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-01-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-19
Last Update Post Date:
2019-01-09
Last Update Post Date Type:
ACTUAL